[go: up one dir, main page]

PE120499A1 - Polimorfo antifungico cristalino - Google Patents

Polimorfo antifungico cristalino

Info

Publication number
PE120499A1
PE120499A1 PE1998000942A PE00094298A PE120499A1 PE 120499 A1 PE120499 A1 PE 120499A1 PE 1998000942 A PE1998000942 A PE 1998000942A PE 00094298 A PE00094298 A PE 00094298A PE 120499 A1 PE120499 A1 PE 120499A1
Authority
PE
Peru
Prior art keywords
crystalline polymorph
antifungal
fenil
triazol
hydroxylpropil
Prior art date
Application number
PE1998000942A
Other languages
English (en)
Inventor
R Andrews David
Leong William
Sudhakar Anantha
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE120499A1 publication Critical patent/PE120499A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE REFIERE A LA FORMA 1 DEL POLIMORFO CRISTALINO DE (-)-4-[4-[4-[4-[[(2R-CIS)-5-(2,4-DIFLUOROFENIL)TETRAHIDRO-5-(1H-1,2,4-TRIAZOL-1-ILMETIL)FURAN-3-IL]METOXI]FENIL]-1-PIPERAZINIL]FENIL-2,4-DIHIDRO-2-[(S)-1-ETIL-2(S)-HIDROXILPROPIL]-3H-1,2,4-TRIAZOL-3-ONA, DE FORMULA I; QUE SE CARACTERIZA POR SUS PROPIEDADES FISICAS COMO a)PATRON DE DIFRACCION DE RAYOS X; b)ESPECTRO INFRARROJO. EL POLIMORFO CRISTALINO PUEDE SER UTIL PARA TRATAR INFECCIONES FUNGICAS EN MAMIFEROS
PE1998000942A 1997-10-07 1998-10-05 Polimorfo antifungico cristalino PE120499A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07

Publications (1)

Publication Number Publication Date
PE120499A1 true PE120499A1 (es) 1999-12-04

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000942A PE120499A1 (es) 1997-10-07 1998-10-05 Polimorfo antifungico cristalino

Country Status (30)

Country Link
EP (1) EP1021439B1 (es)
JP (4) JP2001519346A (es)
KR (1) KR100626109B1 (es)
CN (1) CN1125067C (es)
AR (1) AR015947A1 (es)
AT (1) ATE263163T1 (es)
AU (1) AU759982B2 (es)
BR (1) BR9812866A (es)
CA (1) CA2305803C (es)
CO (1) CO4970829A1 (es)
CZ (1) CZ299835B6 (es)
DE (1) DE69822859T2 (es)
DK (1) DK1021439T3 (es)
ES (1) ES2217594T3 (es)
HU (1) HU225233B1 (es)
ID (1) ID29290A (es)
IL (1) IL135331A (es)
IN (1) IN1998CH02232A (es)
MX (1) MX225999B (es)
MY (1) MY130126A (es)
NO (1) NO318827B1 (es)
NZ (1) NZ503662A (es)
PE (1) PE120499A1 (es)
PH (1) PH11998002606B1 (es)
PL (1) PL189317B1 (es)
PT (1) PT1021439E (es)
SK (1) SK285190B6 (es)
TW (1) TW589310B (es)
WO (1) WO1999018097A1 (es)
ZA (1) ZA989063B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
WO2011144656A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Preparation of posaconazole intermediates
CA2798010C (en) 2010-05-19 2018-09-25 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
RU2585760C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Способ получения хиральных триазолонов
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法
EP2758385B1 (en) * 2011-09-19 2018-03-28 MSN Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
CN105579448B (zh) * 2013-07-25 2018-12-21 桑多斯股份公司 制备泊沙康唑的晶型iv的改进方法
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
LT3209647T (lt) 2014-10-21 2020-09-25 Ariad Pharmaceuticals, Inc. Kristalinės 5-chlor-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il) piperidin-1-il]pirimidin-2,4-diamino formos
EP3590505B1 (en) 2015-08-08 2024-11-06 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP4424308A3 (en) 2016-02-26 2024-12-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
AU681753B2 (en) * 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
PT741737E (pt) * 1994-01-24 2000-04-28 Janssen Pharmaceutica Nv Antifungicos do tipo azole soluveis em agua
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
IL118464A (en) * 1995-06-02 2000-08-13 Schering Corp (2R-cis)-4-¬4-¬4-¬4¬¬-5-(2',4 dihalophenyl)-tetrahydro-5-(1-H-1,2,4,triazol-1-yl-methyl)furan-3-yl(methoxy¾phenyl¾-1-piperazinyl¬phenyl2,4,dihydro2¬(5)-1-ethyl-2-(5)hydroxy propyl¾-3H-1,2,4-triazol-3-one and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
AR015947A1 (es) 2001-05-30
MY130126A (en) 2007-06-29
HUP0004899A2 (hu) 2002-02-28
ZA989063B (en) 1999-04-06
JP2012153730A (ja) 2012-08-16
KR20010030959A (ko) 2001-04-16
HU225233B1 (en) 2006-08-28
ES2217594T3 (es) 2004-11-01
HK1029588A1 (en) 2001-04-06
NZ503662A (en) 2002-10-25
KR100626109B1 (ko) 2006-09-20
MX225999B (es) 2005-02-02
PH11998002606B1 (en) 2006-08-10
CA2305803A1 (en) 1999-04-15
NO20001779D0 (no) 2000-04-06
CA2305803C (en) 2009-12-22
EP1021439A1 (en) 2000-07-26
DK1021439T3 (da) 2004-05-10
NO318827B1 (no) 2005-05-09
ATE263163T1 (de) 2004-04-15
PL189317B1 (pl) 2005-07-29
IN1998CH02232A (es) 2005-03-04
CZ20001264A3 (cs) 2000-08-16
MXPA00003404A (es) 2000-11-01
PL339659A1 (en) 2001-01-02
EP1021439B1 (en) 2004-03-31
DE69822859D1 (de) 2004-05-06
JP2001519346A (ja) 2001-10-23
AU759982B2 (en) 2003-05-01
CN1125067C (zh) 2003-10-22
WO1999018097A1 (en) 1999-04-15
CO4970829A1 (es) 2000-11-07
SK5122000A3 (en) 2000-09-12
DE69822859T2 (de) 2005-01-27
TW589310B (en) 2004-06-01
JP2012153729A (ja) 2012-08-16
NO20001779L (no) 2000-06-06
IL135331A0 (en) 2001-05-20
IL135331A (en) 2005-08-31
CZ299835B6 (cs) 2008-12-10
HUP0004899A3 (en) 2002-03-28
AU9780398A (en) 1999-04-27
BR9812866A (pt) 2000-08-08
CN1281449A (zh) 2001-01-24
PT1021439E (pt) 2004-07-30
SK285190B6 (sk) 2006-08-03
ID29290A (id) 2001-08-16
JP2008106075A (ja) 2008-05-08

Similar Documents

Publication Publication Date Title
PE120499A1 (es) Polimorfo antifungico cristalino
BR0116493A (pt) Compostos de pirazol úteis como inibidores de proteìna cinase
TR200401735T4 (tr) Giraz önleyicileri ve bunların kullanımları
KR950005825A (ko) 4-아미노피리미딘 유도체
BR0212477A (pt) 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças
PE20091618A1 (es) 1,2,4-triazoles trisustituidos
DK0424059T3 (da) Anvendelse af substituerede imidazoler
DE69007740D1 (de) Substituierte 5-[(Tetrazolyl)alkenyl]-Imidazole.
BR9102432A (pt) Processo para o tratamento fungicida foliar e composicao fungicida para a realizacao do processo
BR0313763A (pt) Imidazóis 2,4,5-trissubstituìdos e seu uso como agentes antimicrobianos
UY26253A1 (es) Derivados del triazol y del imidazol
ES2150445T3 (es) Medicamento anti-isquemico.
ATE7598T1 (de) Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.
PE20050950A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
MXPA01008672A (es) Nuevos compuestos heterociclicos de bencensulfonamida, procedimiento de preparacion y utilizacion en terapeutica.
DK0559867T3 (da) Anvendelse af phosphoniumforbindelser ved fremstilling af læder
TR200401347T4 (tr) Yün materyalleri işlemek için silikon bileşikler
ES2176758T3 (es) Procedimiento para la preparacion de 4-ciona-1,2,3-triazxoles.
WO2003086271A3 (en) Azole derivatives as antifungal agents
ES8503680A1 (es) Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
MXPA03010914A (es) DERIVADOS DE HALOFENILO INTERMEDIARIOS Y SU USO EN UN PROCESO PARA LA PREPARACIoN DE DERIVADOS DE AZOL.
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
ATE262339T1 (de) Purinriboside als antiarrhythmika
PT80628A (en) Process for preparing 4(5)-substituted imidazoles
Aisa et al. Il parassitismo nella fauna ittica dell’areale geografico dell’Umbria

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term